Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose CEC and ABMT for Relapsed Germ Cell Cancer
NCT00002943Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Feb 1993
- Primary completion
- Oct 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, etoposide, cyclophosphamide in Germ cell cancer (GCT), solid tumor, sponsored by Wake Forest University Health Sciences. Started Feb 1993; status: completed.
02
Drugs
carboplatinetoposidecyclophosphamide
03
Conditions
Germ cell cancer (GCT)solid tumor
Beyond the preview
Go deeper on NCT00002943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002943.